KEGG   DRUG: Lamivudine and raltegravir
Entry
D10754            Mixture   Drug                                   
Name
Lamivudine and raltegravir;
Lamivudine and raltegravir potassium;
Dutrebis (TN)
Component
Lamivudine [DR:D00353], (Raltegravir potassium [DR:D07133] | Raltegravir [DR:D06676])
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
ATC code: J05AR16
Efficacy
Antiviral
Comment
Treatment of HIV infection
Target
HIV-1 reverse transcriptase [KO:K24802]
HIV-1 integrase [KO:K24803]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR16 Lamivudine and raltegravir
      D10754  Lamivudine and raltegravir
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D10754  Lamivudine and raltegravir
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV integrase inhibitor
    D10754  Lamivudine and raltegravir
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10754
Other DBs
PubChem: 273220350
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system